Breaking News Instant updates and real-time market news.

F

Ford

$9.17

0.105 (1.16%)

16:07
10/23/19
10/23
16:07
10/23/19
16:07

Ford reports Q3 EPS adjusted EPS 34c, consensus 26c

Reports Q3 revenue $37.0B, consensus $33.98B. Adjusted EBIT in the quarter increased 8 percent to $1.8B.. The higher operating results were attributable to mark-to-market investment gains; improvement in the company's businesses in North America, Europe and China; and another strong performance by Ford Credit.

  • 23

    Oct

F Ford
$9.17

0.105 (1.16%)

10/01/19
BUCK
10/01/19
NO CHANGE
Target $8
BUCK
Neutral
Ford price target lowered to $8 from $9 at Buckingham
Buckingham analyst Joseph Amaturo maintained a Neutral rating on Ford and lowered his price target to $8 from $9, citing a more cautious view of earnings per share and free cash flow for the second half of the year as well as heightened concerns for 2020. Amaturo tells investors in a research note that he is "pretty confident" Ford will fall meaningfully short of EPS and adjusted free cash flow expectations for the third quarter when it reports on October 23, and says he is becoming increasingly concerned about end market demand in many of the markets it participates in.
09/27/19
MSCO
09/27/19
NO CHANGE
Target $12
MSCO
Overweight
Ford Q3 may lack 'punch,' but weakness would be opportunity, says Morgan Stanley
Morgan Stanley analyst Adam Jonas lowered his 2019 EPS forecast for Ford to $1.22 from $1.30 to account for his inclusion of estimated UAW contract ratification costs and also pointed to headwinds related to a challenging ramp-up of Explorer in Q3 and more losses from China imports in the second half. While he thinks Ford's Q3 report "may not pack a big punch," Jonas would see any related weakness in Ford shares as a buying opportunity as he is attracted to low expectations for Ford in the equity and debt markets. Jonas, who added that he likes the current setup for Ford "very much," reiterated his Overweight rating and $12 price target on the shares.
09/18/19
MSCO
09/18/19
NO CHANGE
Target $12
MSCO
Overweight
Ford details on EVs, cost savings to be catalysts, says Morgan Stanley
Morgan Stanley analyst Adam Jonas, in a note to investors titled "Ford Ready to Shock with BEV and Cost Savings?," said his conviction has increased, based on investor positioning and low expectations for Ford in the equity and debt market, that the company offering details around its battery electric vehicle plans and cost savings expectations can be catalysts for the stock. Ford has communicated $11B of restructuring charges, but hasn't made clear any annual savings targets so that consensus forecasts don't include them, Jonas said. He currently gives Ford credit for roughly $1B of restructuring savings and expects the company to outline its savings forecasts to the investment community within the next two quarters. Jonas, who also expect Ford's electrification strategy to shift from hybrids to battery electric over the next 24 months, reiterated his Overweight rating and $12 price target on Ford shares.
09/10/19
BOFA
09/10/19
NO CHANGE
Target $13
BOFA
Buy
Ford downgrade by Moody's may be sign of things to come, says BofA/Merrill
BofA Merrill Lynch analyst John Murphy said Ford's corporate borrowing costs will likely remain unchanged in the near-term despite Moody's downgrade of the company's senior unsecured rating to Ba1, or a junk status, since Ford faces no significant near-term debt maturities. While the financial implications seem "somewhat de minimis at present," Moody's move on Ford's credit rating could be a harbinger of future downgrades for the company and even for the broader automotive value chain, particularly for those undergoing turnaround efforts, said Murphy. While he does not disagree with many of the concerns raised by Moody's, Murphy thinks Ford's dividend will be maintained for the foreseeable future and views the near-term product cycle as robust. He also believes improved execution and communication may help Ford's multiple to recover despite the "somewhat disappointing" downgrade news, leading Murphy to keep a Buy rating on Ford shares.

TODAY'S FREE FLY STORIES

BXRX

Baudax Bio

$4.66

-0.59 (-11.24%)

07:24
11/22/19
11/22
07:24
11/22/19
07:24
Initiation
Baudax Bio initiated  »

Baudax Bio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$53.89

1.41 (2.69%)

07:23
11/22/19
11/22
07:23
11/22/19
07:23
Initiation
Biohaven Pharmaceutical initiated  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$56.84

0.455 (0.81%)

07:23
11/22/19
11/22
07:23
11/22/19
07:23
Initiation
Bristol-Myers initiated  »

Bristol-Myers resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENR

Energizer

$49.05

1.33 (2.79%)

07:22
11/22/19
11/22
07:22
11/22/19
07:22
Recommendations
Energizer analyst commentary  »

Energizer Analyst Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,734.99

-10.51 (-0.60%)

, MSFT

Microsoft

$149.46

-0.14 (-0.09%)

07:20
11/22/19
11/22
07:20
11/22/19
07:20
Periodicals
Amazon suit to likely delay start of Pentagon technology program, Bloomberg says »

Amazon (AMZN) could…

AMZN

Amazon.com

$1,734.99

-10.51 (-0.60%)

MSFT

Microsoft

$149.46

-0.14 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 04

    Dec

  • 09

    Dec

ABCB

Ameris Bancorp

$42.81

-0.4 (-0.93%)

07:19
11/22/19
11/22
07:19
11/22/19
07:19
Recommendations
Ameris Bancorp analyst commentary  »

Ameris Bancorp subpoena…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BWEN

Broadwind Energy

$1.44

-0.06 (-4.00%)

07:18
11/22/19
11/22
07:18
11/22/19
07:18
Hot Stocks
Broadwind Energy receives first solar market order »

Broadwind Energy has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTC

Astrotech

$1.51

-0.06 (-3.83%)

07:18
11/22/19
11/22
07:18
11/22/19
07:18
Hot Stocks
Astrotech says 1st Detect sells TRACER 1000s to shipping & logistics company »

Astrotech Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGS

Medigus

$1.76

(0.00%)

07:17
11/22/19
11/22
07:17
11/22/19
07:17
Hot Stocks
Medigus receives $1.2M payment as part of MUSE agreement in China »

Medigus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:16
11/22/19
11/22
07:16
11/22/19
07:16
Hot Stocks
Breaking Hot Stocks news story on Destination XL »

Destination XL to close…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

T

AT&T

$37.59

0.415 (1.12%)

07:15
11/22/19
11/22
07:15
11/22/19
07:15
Recommendations
AT&T analyst commentary  »

AT&T near-term short…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 29

    Jan

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:15
11/22/19
11/22
07:15
11/22/19
07:15
Hot Stocks
Destination XL expects FY19 free cash flow to be breakeven »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

ANIX

Anixa Biosciences

$3.50

-0.11 (-3.05%)

07:13
11/22/19
11/22
07:13
11/22/19
07:13
Hot Stocks
Anixa Biosciences announces Cchek study collaboration with UCA »

Anixa Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:13
11/22/19
11/22
07:13
11/22/19
07:13
Earnings
Destination XL reports Q3 adj. EPS (8c) vs. (2c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

DXLG

Destination XL

$1.45

-0.02 (-1.36%)

07:11
11/22/19
11/22
07:11
11/22/19
07:11
Hot Stocks
Destination XL announces Ujjwal Dhoot as chief digital officer »

Destination XL announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

TREE

LendingTree

$365.30

-5.29 (-1.43%)

07:11
11/22/19
11/22
07:11
11/22/19
07:11
Initiation
LendingTree initiated  »

JPMorgan starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ENR

Energizer

$49.05

1.33 (2.79%)

07:09
11/22/19
11/22
07:09
11/22/19
07:09
Hot Stocks
Energizer targets 'top-line growth above category' in FY20-FY22 »

Also targets adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCN

Neovasc

$2.85

-0.05 (-1.72%)

07:08
11/22/19
11/22
07:08
11/22/19
07:08
Hot Stocks
Neovasc says Reducer featured during therapy development program in Coburg »

Neovasc announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$60.22

0.85 (1.43%)

07:08
11/22/19
11/22
07:08
11/22/19
07:08
Recommendations
ConocoPhillips analyst commentary  »

ConocoPhillips price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJM

J.M. Smucker

$104.40

-1.15 (-1.09%)

07:08
11/22/19
11/22
07:08
11/22/19
07:08
Hot Stocks
J.M. Smucker CEO says Q2 sales performance did not meet expectations »

"While our second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

LHCG

LHC Group

$131.10

0.57 (0.44%)

07:06
11/22/19
11/22
07:06
11/22/19
07:06
Hot Stocks
LHC Group, Texas Health, Methodist Health purchase Healthcare Resources »

LHC Group, Texas Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 05

    Dec

SJM

J.M. Smucker

$104.40

-1.15 (-1.09%)

07:06
11/22/19
11/22
07:06
11/22/19
07:06
Earnings
J.M. Smucker cuts FY20 adj. EPS view to $8.10-$8.30 from $8.35-$8.55 »

Consensus $8.27. Cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

RMR

RMR Group

$48.26

0.02 (0.04%)

07:06
11/22/19
11/22
07:06
11/22/19
07:06
Earnings
RMR Group reports Q4 adj. EPS 59c, consensus 52c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

NAVB

Navidea

$0.71

-0.0322 (-4.34%)

07:05
11/22/19
11/22
07:05
11/22/19
07:05
Initiation
Navidea initiated  »

Navidea initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:05
11/22/19
11/22
07:05
11/22/19
07:05
General news
FX Update: The dollar has been trading steady-to-firmer »

FX Update: The dollar has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.